glp 1 side effects hair loss One of the most common concerns I'm seeing in patients taking GLP-1 medications is loss. For some, it shows up as increased shedding; for others, it can be more dramatic with Weight loss is often the
Description
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal
Emanuel EJ, Dellgren JL, McCoy MS

This 10/10 recipe features tender chicken with a tangy sugar-free BBQ sauce, piled high with fresh veggies

This simple, easy-to-follow GLP-1 food guide helps you make confident food choices without overthinking

As new uses emerge, companies must carefully monitor patient health and integrate behavior change strategies
